263 related articles for article (PubMed ID: 15910812)
1. Heterocyclic isosters of antimycobacterial salicylanilides.
Matyk J; Waisser K; Drazková K; Kunes J; Klimesová V; Palát K; Kaustová J
Farmaco; 2005 May; 60(5):399-408. PubMed ID: 15910812
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
Waisser K; Drazková K; Kunes J; Klimesová V; Kaustová J
Farmaco; 2004 Aug; 59(8):615-25. PubMed ID: 15262531
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial and antifungal isosters of salicylamides.
Waisser K; Pesina M; Holý P; Pour M; Bures O; Kunes J; Klimesová V; Buchta V; Kubanová P; Kaustová J
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):322-35. PubMed ID: 12953220
[TBL] [Abstract][Full Text] [Related]
5. Salicylanilide and its heterocyclic analogues. A comparative study of their antimicrobial activity.
Daidone G; Maggio B; Schillaci D
Pharmazie; 1990 Jun; 45(6):441-2. PubMed ID: 2402534
[No Abstract] [Full Text] [Related]
6. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides.
Waisser K; Kunes J; Odlerová Z; Roman M; Kubicová L; Horák V
Pharmazie; 1998 Mar; 53(3):193-5. PubMed ID: 9547521
[TBL] [Abstract][Full Text] [Related]
10. Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
Adamec J; Beckert R; Weiss D; Klimesová V; Waisser K; Möllmann U; Kaustová J; Buchta V
Bioorg Med Chem; 2007 Apr; 15(8):2898-906. PubMed ID: 17321746
[TBL] [Abstract][Full Text] [Related]
11. New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species.
Pauk K; Zadražilová I; Imramovský A; Vinšová J; Pokorná M; Masaříková M; Cížek A; Jampílek J
Bioorg Med Chem; 2013 Nov; 21(21):6574-81. PubMed ID: 24045008
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
Gasparová R; Lácová M; el-Shaaer HM; Odlerová Z
Farmaco; 1997 Apr; 52(4):251-3. PubMed ID: 9241831
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides.
Zitko J; Dolezal M; Svobodova M; Vejsova M; Kunes J; Kucera R; Jilek P
Bioorg Med Chem; 2011 Feb; 19(4):1471-6. PubMed ID: 21273083
[TBL] [Abstract][Full Text] [Related]
14. [A new group of potential antitubercular agents: antimycobacterial N-benzylsalicylamides].
Waisser K; Perina M; Boudová I; Kunes J; Kaustová J
Ceska Slov Farm; 2003 Nov; 52(6):291-4. PubMed ID: 14661368
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a new series of heterocyclic scaffolds for medicinal purposes.
Hilal HS; Ali-Shtayeh MS; Arafat R; Al-Tel T; Voelter W; Barakat A
Eur J Med Chem; 2006 Aug; 41(8):1017-24. PubMed ID: 16797790
[TBL] [Abstract][Full Text] [Related]
16. A note to the biological activity of benzoxazine derivatives containing the thioxo group.
Waisser K; Petrlíková E; Perina M; Klimesová V; Kunes J; Palát K; Kaustová J; Dahse HM; Möllmann U
Eur J Med Chem; 2010 Jul; 45(7):2719-25. PubMed ID: 20226572
[TBL] [Abstract][Full Text] [Related]
17. Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues.
Monga V; Nayyar A; Vaitilingam B; Palde PB; Jhamb SS; Kaur S; Singh PP; Jain R
Bioorg Med Chem; 2004 Dec; 12(24):6465-72. PubMed ID: 15556764
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and antibacterial activities of some N-bridged heterocycles containing triazole, quinoline and nitrofuran moieties.
Holla BS; Shridhara K; Rao BS; Poojary KN
Boll Chim Farm; 2002; 141(2):105-9. PubMed ID: 12135157
[TBL] [Abstract][Full Text] [Related]
19. 3-Benzyl-2H-1,3-benzoxazine-2,4(3H)-diones, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Perina M; Kunes J; Klimesová V; Kaustová J
Farmaco; 2003 Nov; 58(11):1137-49. PubMed ID: 14572865
[TBL] [Abstract][Full Text] [Related]
20. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
Dolezal R; Van Damme S; Bultinck P; Waisser K
Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
